Refractory Evans syndrome after autologous stem cell transplantation for multiple myeloma: management with a second transplantation.
The development of autoimmune disease after autologous stem cell transplantation (ASCT) is very rare in multiple myeloma (MM). We describe the first case of Evans syndrome after ASCT for MM. A 60-year-old man with MM received ASCT and subsequently developed Evans syndrome following two febrile episodes. The syndrome was refractory to conventional therapies but it was managed with a second ASCT. This unique complication was thought to have been triggered by an infection during the recovery of the immune system. We assumed that reconstructing the immune system via ASCT might eliminate infection-induced autoantibodies to platelets and erythrocytes.
Chihara
Dai
D
Division of Hematology and Immunology, Department of Internal Medicine, Ohtsu Red Cross Hospital, Ohtsu.
Sakamoto
Takashi
T
Arimoto-Miyamoto
Kazue
K
Kishimoto
Wataru
W
Takeoka
Tomoharu
T
Tsuji
Masaaki
M
Ohno
Tatsuharu
T
D001327:Autoimmune Diseases / Q000175:diagnosis / Q000209:etiology* / Q000601:surgery*; D019468:Disease Management; D017809:Fatal Outcome; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects* / Q000379:methods; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000473:pathology / Q000601:surgery*; D013577:Syndrome; D019172:Transplantation Conditioning; D014182:Transplantation, Autologous